Federated Hermes’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.4M Buy
1,308,199
+1,016,069
+348% +$17.4M 0.04% 400
2025
Q1
$18.6M Sell
292,130
-88,288
-23% -$5.63M 0.04% 416
2024
Q4
$46.3M Sell
380,418
-128,418
-25% -$15.6M 0.1% 248
2024
Q3
$63.5M Buy
508,836
+507
+0.1% +$63.3K 0.14% 191
2024
Q2
$80.3M Sell
508,329
-101,887
-17% -$16.1M 0.19% 132
2024
Q1
$79M Sell
610,216
-98,174
-14% -$12.7M 0.18% 149
2023
Q4
$68.3M Sell
708,390
-254,659
-26% -$24.6M 0.17% 157
2023
Q3
$117M Sell
963,049
-1,898
-0.2% -$230K 0.31% 70
2023
Q2
$111M Buy
964,947
+148,025
+18% +$17M 0.27% 77
2023
Q1
$113M Buy
816,922
+37,479
+5% +$5.17M 0.28% 76
2022
Q4
$101M Buy
779,443
+4,569
+0.6% +$592K 0.28% 68
2022
Q3
$85.7M Buy
774,874
+70,774
+10% +$7.82M 0.25% 89
2022
Q2
$52.8M Buy
704,100
+517
+0.1% +$38.8K 0.14% 192
2022
Q1
$55M Buy
703,583
+24,609
+4% +$1.92M 0.12% 213
2021
Q4
$61.1M Buy
678,974
+350,033
+106% +$31.5M 0.11% 233
2021
Q3
$30.4M Buy
328,941
+102,858
+45% +$9.51M 0.06% 384
2021
Q2
$17.6M Sell
226,083
-55,452
-20% -$4.31M 0.03% 510
2021
Q1
$21M Sell
281,535
-2,391
-0.8% -$178K 0.04% 482
2020
Q4
$48.4M Sell
283,926
-24,867
-8% -$4.24M 0.1% 256
2020
Q3
$43.4M Buy
308,793
+85,003
+38% +$11.9M 0.1% 231
2020
Q2
$35.9M Buy
223,790
+25,086
+13% +$4.02M 0.09% 264
2020
Q1
$19.4M Buy
198,704
+97,326
+96% +$9.52M 0.06% 338
2019
Q4
$13.1M Buy
+101,378
New +$13.1M 0.03% 535
2019
Q1
Sell
-26
Closed -$3K 2225
2018
Q4
$3K Sell
26
-9,415
-100% -$1.09M ﹤0.01% 2051
2018
Q3
$1.53M Sell
9,441
-10,270
-52% -$1.66M ﹤0.01% 1207
2018
Q2
$2.61M Sell
19,711
-33,658
-63% -$4.45M 0.01% 903
2018
Q1
$3.95M Buy
53,369
+4,460
+9% +$330K 0.01% 702
2017
Q4
$2.72M Buy
+48,909
New +$2.72M 0.01% 818
2016
Q4
Sell
-3,887
Closed -$239K 2158
2016
Q3
$239K Buy
+3,887
New +$239K ﹤0.01% 1448
2013
Q4
Sell
-30,000
Closed -$1.42M 1795
2013
Q3
$1.42M Buy
+30,000
New +$1.42M 0.01% 1029